Chenjie He

457 total citations
8 papers, 303 citations indexed

About

Chenjie He is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chenjie He has authored 8 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Chenjie He's work include Metabolomics and Mass Spectrometry Studies (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Chenjie He is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Chenjie He collaborates with scholars based in China. Chenjie He's co-authors include Zihang Zeng, Yiming Ma, Yan Chen, Xiangming Liu, Huanhuan Lu, Ruoyun Ouyang, Dandan Zong, Herui Li, Yanan Cui and Lijuan Luo and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Pharmacology and Journal of Neuroinflammation.

In The Last Decade

Chenjie He

8 papers receiving 302 citations

Peers

Chenjie He
Chenjie He
Citations per year, relative to Chenjie He Chenjie He (= 1×) peers Maria Tafelmeier

Countries citing papers authored by Chenjie He

Since Specialization
Citations

This map shows the geographic impact of Chenjie He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenjie He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenjie He more than expected).

Fields of papers citing papers by Chenjie He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenjie He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenjie He. The network helps show where Chenjie He may publish in the future.

Co-authorship network of co-authors of Chenjie He

This figure shows the co-authorship network connecting the top 25 collaborators of Chenjie He. A scholar is included among the top collaborators of Chenjie He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenjie He. Chenjie He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ma, Yiming, Chenjie He, Xiangming Liu, et al.. (2021). C-Reactive Protein to Serum Albumin Ratio as a Novel Biomarker to Predict Prognosis in Patients with Chronic Obstructive Pulmonary Disease. Clinical Laboratory. 67(03/2021). 9 indexed citations
2.
Liu, Xiangming, Yiming Ma, Ruoyun Ouyang, et al.. (2020). The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome. Journal of Neuroinflammation. 17(1). 229–229. 138 indexed citations
3.
Ma, Yiming, Huihui Zeng, Huanhuan Lu, et al.. (2020). Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China. Frontiers in Pharmacology. 11. 1198–1198. 27 indexed citations
4.
Ma, Yiming, Dandan Zong, Herui Li, et al.. (2019). Feasibility of mean platelet volume as a biomarker for chronic obstructive pulmonary disease: A systematic review and meta-analysis. Journal of International Medical Research. 47(12). 5937–5949. 5 indexed citations
5.
Peng, Feng, Yingzi Liu, Chenjie He, et al.. (2018). Prediction of platinum-based chemotherapy efficacy in lung cancer based on LC–MS metabolomics approach. Journal of Pharmaceutical and Biomedical Analysis. 154. 95–101. 18 indexed citations
6.
He, Chenjie, Yongbin Liu, Jie Tang, et al.. (2018). 1H NMR based pharmacometabolomics analysis of metabolic phenotype on predicting metabolism characteristics of losartan in healthy volunteers. Journal of Chromatography B. 1095. 15–23. 8 indexed citations
7.
Peng, Jingbo, Yi‐Cheng Wang, Mu-Peng Li, et al.. (2017). An HPLC-MS/MS Method for the Quantitative Determination of Ticagrelor and its Active Metabolite AR-C124910XX in Human Plasma and its Application to a Clinical Study. Current Pharmaceutical Analysis. 13(3). 296–303. 7 indexed citations
8.
Lv, Qiao‐Li, Lei Hu, Shuhui Chen, et al.. (2016). A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma. International Journal of Molecular Sciences. 17(9). 1431–1431. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026